K. Ahmad et al. / Tetrahedron 65 (2009) 1504–1516
1515
128.7 (C-12), 124.3 (C-13), 122.0 (C-11), 117.6 (C-8), 104.7 (C-2, C-6),
100.2 (C-4), 55.3 (2ꢄOCH3), 24.2 (C-16).
H-6, H-60, 4H), 4.66 (s, H-7, H-70, 2H), 3.69 (s, 2ꢄOCH3, 6H), 3.48 (s,
H-8, H-80, 2H), 1.87 (s, 2ꢄCH3, 6H). 13C NMR (100 MHz, CDCl3)
d
ppm: 169.8 (C-15, C-150), 159.1 (C-4, C-40), 143.9 (C-10, C-100),
4.4. Phase IV: ferric chloride oxidative coupling and
cyclization
133.9 (C-1, C-10), 130.1 (C-9, C-90), 129.4 (C-12, C-120), 125.7 (C-2,
C-20, C-6, C-60), 125.3 (C-14, C-140), 125.0 (C-13, C-130), 117.7 (C-11,
C-110), 114.5 (C-3, C-30, C-5, C-50), 64.2 (C-7, C-70), 56.8 (C-8, C-80),
55.3 (OCH3), 23.7 (C-16, C-160).
Acetamidostilbene 23 (0.2775 g, 0.9343 mmol) was dissolved in
10 mL dichloromethane. ‘Anhydrous’ FeCl3 (0.7578 g, 4.672 mmol)
was then added to the mixture under nitrogen. The mixture was
stirred for 7 h at room temperature and monitored by TLC. After the
consumption of the starting material, the reaction mixture was
diluted with an aqueous ammonium chloride solution and extrac-
ted with ethyl acetate (3ꢄ25 mL). The combined ethyl acetate ex-
tracts were dried over anhydrous sodium sulfate. The crude
product was finally purified by column chromatography (hexane/
ethyl acetate; 80:20, 70:40; toluene/ethyl acetate; 80:20 and
70:30), which afforded four compounds, 37,41 38, 39 and 40 in 2.4%
(12 mg), 8% (18 mg), 14% (18 mg) and 10% (13 mg) yields,
respectively.
The reaction described above was repeated on stilbenes 21
(0.0978 g, 36.629 mmol) and 22 (0.1089 g, 40.787 mmol). To each of
these stilbenes in 10 mL dichloromethane, anhydrous FeCl3
(0.2348 g, 1.4475 mmol and 0.3116 g, 1.921 mmol) was added, re-
spectively, which resulted in the formation of indoline 34 (6 mg, 6%,
hexane/ethyl acetate, 80:20), indoline 35 (18 mg, 16%, hexane/ethyl
acetate, 85:15) and bisindoline 36 (13 mg, 24%, hexane/ethyl
acetate, 80:20), respectively.
4.4.4. N-(2-Formylphenyl)acetamide (37)41
MS m/z: 163 [Mþ]; UV (MeOH) lmax nm: 223; IR nmax cmꢃ1
:
3270, 1660. 1H NMR (400 MHz, CDCl3)
d ppm: 11.11 (s, N-H, 1H),
9.90 (s, H-17, 1H), 8.71 (d, J¼8.7 Hz, H-11, 1H), 7.65 (dd, J¼1.8, 7.8 Hz,
H-14, 1H), 7.60 (t, J¼8.7 Hz, H-12, 1H), 7.21 (t, J¼7.8 Hz, H-13, 1H),
2.24 (s, CH3, 3H). 13C NMR (100 MHz, CDCl3)
d ppm: 195.7 (C-17),
169.8 (C-15), 141.0 (C-10), 136.3 (C-12), 136.2 (C-14), 123.0 (C-13),
121.6 (C-9), 119.9 (C-11), 25.5 (C-16).
4.4.5. N-{2-[(E)-2-(2,6-Dichloro-3,5-dimethoxyphenyl)-
ethenyl]phenyl}acetamide (38)
HRESIMS m/z: 388.0463 ([MþNa]þ; calcd for C18H17NO3NaCl2,
388.0483); UV (MeOH) lmax nm: 223; IR nmax cmꢃ1: 3475, 1738,
1213, 802, 747. 1H NMR (400 MHz, CDCl3)
d
ppm: 7.97 (d, J¼8.0 Hz,
H-11, 1H), 7.52 (d, J¼8.0 Hz, H-14, 1H), 7.31 (t, J¼8.0 Hz, H-12, 1H),
7.17 (t, J¼8.0 Hz, H-13, 1H), 7.09 (d, J¼17.0 Hz, H-8, 1H), 6.87 (d,
J¼17.0 Hz, H-7, 1H), 6.52 (s, H-4, 1H), 3.92 (s, 2ꢄOCH3, 6H), 2.18 (s,
CH3, 3H). 13C NMR (100 MHz, CDCl3)
d ppm: 168.6 (C-15), 154.7
(C-3, C-5), 136.1 (C-1), 135.2 (C-10), 132.9 (C-8), 129.2 (C-9), 129.0
(C-12), 127.4 (C-7, C-14), 125.2 (C-13), 123.1 (C-11), 114.0 (C-2, C-6),
96.4 (C-4), 56.7 (2ꢄOCH3), 24.3 (C-16).
4.4.1. 1-[2-(3-Methoxyphenyl)-2,3-dihydro-1H-indol-1-yl]-1-
ethanone (34)
HRESIMS m/z: 268.1325 ([MþH]þ; calcd for C17H18NO2,
4.4.6. N-(2-{(E)-2-[20-(1-Acetyl-1H-indol-2-yl)-30chloro-4,40,6,60-
tetramethoxy[1,10-biphenyl]-2-yl]ethenyl}phenyl)acetamide (39)
HRESIMS m/z: 648.1998 ([MþNa]þ; calcd for C36H33ClN2NaO6,
648.1998); UV (MeOH) lmax nm: 302, 270, 202; IR nmax cmꢃ1: 3378,
268.1338); UV (MeOH) lmax nm: 280, 252, 239, 213; IR nmax cmꢃ1
:
3001, 1662, 1049, 752. 1H NMR (400 MHz, CDCl3)
d ppm: 8.30 (d,
J¼8.0 Hz, H-11, 1H), 7.25 (t, J¼8.0 Hz, H-12, 1H), 7.22 (d, J¼8.0 Hz, H-
4, 1H), 7.12 (d, J¼8.0 Hz, H-14, 1H), 7.04 (t, J¼8.0 Hz, H-13, 1H), 6.78
(d, J¼8.0 Hz, H-6, 1H), 6.75 (t, J¼8.0 Hz, H-5, 1H), 6.70 (s, H-2, 1H),
2969,1738, 1218, 775. 1H NMR (400 MHz, CDCl3)
d ppm: 8.86 (s, NH,
1H), 8.03 (d, J¼8.2 Hz, H-110, 1H), 7.85 (d, J¼8.2 Hz, H-11, H-14, 2H),
7.39 (d, J¼8.2 Hz, H-140, 1H), 7.26 (t, J¼8.2 Hz, H-12, 1H), 7.21 (t,
J¼8.2 Hz, H-120, 1H), 7.16 (t, J¼8.2 Hz, H-130, 1H), 7.08 (t, J¼8.2 Hz,
H-13, 1H), 6.82 (d, J¼16.0 Hz, H-8, 1H), 6.72 (s, H-40, 1H), 6.65 (d,
J¼16.0 Hz, H-7, 1H), 6.48 (s, H-6, 1H), 6.42 (s, H-80, 1H), 6.08 (s, H-4,
1H), 3.99 (s, 50-OCH3, 3H), 3.85 (s, 30-OCH3, 3H), 3.67 (s, 5-OCH3,
3H), 3.59 (s, 3-OCH3, 3H), 2.36 (s, CH3, 3H), 1.88 (s, CH3, 3H). 13C
5.34 (d, J¼9.0 Hz, H-7, 1H), 3.80 (dd, J¼16.0, 9.0 Hz, H-8
b
, 1H), 3.67
, 1H), 2.05 (s, CH3, 3H).
ppm: 169.7 (C-15), 160.2 (C-3), 144.8
(s, OCH3, 3H), 2.98 (dd, J¼16.0, 2.0 Hz, H-8
a
13C NMR (100 MHz, CDCl3)
d
(C-10), 143.3 (C-1), 130.4 (C-4), 129.2 (C-9), 127.8 (C-12), 124.9 (C-
14), 124.1 (C-13), 117.3 (C-5), 117.0 (C-11), 112.7 (C-6), 111.0 (C-2),
63.5 (C-7), 55.2 (OCH3), 38.9 (C-8), 24.2 (C-16).
NMR (100 MHz, CDCl3) d
ppm: 172.3 (C-150), 169.7 (C-15), 160.2 (C-
4.4.2. 1-[2-(4-Methoxyphenyl)-2,3-dihydro-1H-indol-1-yl]-1-
ethanone (35)
5), 157.7 (C-3), 156.4 (C-30), 155.5 (C-50), 138.9 (C-1), 136.5 (C-100),
136.4 (C-70), 135.6 (C-10), 134.4 (C-10), 131.1 (C-7), 130.4 (C-9), 129.0
(C-90), 128.5 (C-12), 128.0 (C-8), 127.3 (C-14), 125.0 (C-13), 124.9 (C-
11), 124.8 (C-120), 123.6 (C-130), 120.6 (C-20), 120.4 (C-140), 116.1 (C-
2),115.8 (C-110), 115.7 (C-60),112.6 (C-80),102.5 (C-6), 98.1 (C-4), 97.5
(C-40), 56.6 (50-OCH3), 56.4 (30-OCH3), 55.4 (3-OCH3), 55.3 (5-
OCH3), 26.3 (C-160), 24.2 (C-16).
HRESIMS m/z: 268.1330 ([MþH]þ; calcd for C17H18NO2,
268.1338); UV (MeOH) lmax nm: 281, 252, 238, 213; IR nmax cmꢃ1
:
3002, 1663, 1049, 752. 1H NMR (400 MHz, CDCl3)
d ppm: 8.28 (d,
J¼8.0 Hz, H-11, 1H), 7.25 (t, J¼8.0 Hz, H-12, 1H), 7.10 (d, J¼8.0 Hz,
H-14, 1H), 7.05 (d, J¼8.0 Hz, H-2, H-6, 2H), 7.03 (t, J¼8.0 Hz, H-13,
1H), 6.80 (d, J¼8.0 Hz, H-3, H-5, 2H), 5.30 (d, J¼10.0 Hz, H-7, 1H),
3.75 (dd, J¼16.0, 10.0 Hz, H-8
J¼16.0, 2.0 Hz, H-8
CDCl3) ppm: 169.7 (C-15), 159.2 (C-4), 143.4 (C-10), 135.3 (C-1),
b
, 1H), 3.74 (s, OCH3, 3H), 2.92 (dd,
4.4.7. N-(2-{(E)-2-[20-(1-Acetyl-1H-indol-2-yl)-30chloro-2,40,6,60-
tetramethoxy[1,10-biphenyl]-4-yl]ethenyl}phenyl)acetamide (40)
HRESIMS m/z: 625.2111 ([MþH]þ; calcd for C36H34ClN2O6,
625.2105); UV (MeOH) lmax nm: 298, 240, 202; IR nmax cmꢃ1: 3675,
a
, 1H), 2.02 (s, CH3, 3H). 13C NMR (100 MHz,
d
129.3 (C-9), 127.8 (C-12), 126.2 (C-2, C-6), 125.0 (C-14), 124.1 (C-13),
117.1 (C-11), 114.5 (C-3, C-5), 63.2 (C-7), 55.4 (OCH3), 39.1 (C-8),
24.2 (C-16).
3016, 2970, 1738, 1217, 772. 1H NMR (400 MHz, CDCl3)
d ppm: 8.34
(d, J¼8.2 Hz, H-110, 1H), 7.76 (d, J¼7.8 Hz, H-11, 1H), 7.39 (d,
J¼8.2 Hz, H-140,1H), 7.37 (d, J¼7.8 Hz, H-14,1H), 7.25 (t, J¼7.8 Hz, H-
12,1H), 7.22 (t, J¼8.2 Hz, H-120, 1H), 7.19 (t, J¼8.2 Hz, H-130, 1H), 7.13
(t, J¼7.8 Hz, H-13, 1H), 6.96 (d, J¼16.0 Hz, H-8, 1H), 6.77 (d,
J¼16.0 Hz, H-7, 1H), 6.72 (s, H-40, 1H), 6.48 (s, H-2, H-6, 2H), 6.36 (s,
H-80, 1H), 4.00 (s, 30-OCH3, 3H), 3.78 (s, 3-OCH3, 3H), 3.74 (s, 50-
OCH3, 3H), 3.61 (s, 5-OCH3, 3H), 2.30 (s, CH3, 3H), 2.14 (s, CH3, 3H).
4.4.3. Bis-1-[2-(4-methoxyphenyl)-2,3-dihydro-1H-indol-1-yl]-1-
ethanone (36)
HRESIMS m/z: 533.2430 ([MþH]þ; calcd for C34H33N2O4,
533.2440); UV (MeOH) lmax nm: 282, 252, 239, 214; IR nmax cmꢃ1
:
1668, 1049, 752. 1H NMR (400 MHz, CDCl3)
d ppm: 8.45 (d,
J¼8.0 Hz, H-11, H-110, 2H), 7.46 (t, J¼8.0 Hz, H-12, H-120, 2H), 7.27 (d,
J¼8.0 Hz, H-14, H-140, 2H), 7.25 (t, J¼8.0 Hz, H-13, H-130, 2H), 6.66
(d, J¼9.0 Hz, H-3, H-30, H-5, H-50, 4H), 6.43 (d, J¼9.0 Hz, H-2, H-20,
13C NMR (100 MHz, CDCl3) ppm: 171.4 (C-150), 168.8 (C-15), 158.3
d
(C-50), 157.7 (C-5), 157.5 (C-3), 155.3 (C-30), 138.2 (C-1), 137.0 (C-100),
135.7 (C-70), 134.7 (C-10), 134.7 (C-10), 133.1 (C-7), 130.3 (C-9), 129.1